DEFINIUM THERAPEUTICS INC

Historical 13F Holders

Symbol
DFTX
CUSIP
24477V105
All holders as of
Q2 2026
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 24477V105 since 12/18/2024, newest first.

Filer % of Class Filed
Commodore Capital LP 13G/A Amendment 3
1.8% 8/14/2026
Event 6/30/2026
Driehaus Capital Management LLC 13G/A Amendment 1 5.4% 8/14/2026
Event 6/30/2026
Deep Track Capital, LP 13G/A Amendment 4
3.0% 5/15/2026
Event 3/31/2026
Commodore Capital LP 13G/A Amendment 2
7.2% 2/17/2026
Event 12/31/2025
Driehaus Capital Management LLC 13G 6.6% 2/17/2026
Event 12/31/2025
Avoro Capital Advisors LLC 13G
5.1% 2/17/2026
Event 12/31/2025
Deep Track Capital, LP 13G/A Amendment 3
5.5% 2/13/2026
Event 12/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 8 41.8 k $1.59 M
2026 Q2 391 121 M $5.48 B
2026 Q1 263 78.4 M $1.48 B
2025 Q4 8 11.3 M $151 M